← Back to Search

Physical Activity for Lymphoblastic Leukemia

N/A

Recruiting

Led By Andrea Orsey, MD

Research Sponsored by Connecticut Children's Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have no documented or observable psychiatric or neurological disorders that would interfere with study participation

Pediatric oncology patients with ALL in the maintenance phase of chemotherapy during the time of study

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 1 year

Awards & highlights

Study Summary

This trial looks at how exercise affects kids with leukemia who are receiving maintenance chemotherapy.

Who is the study for?

This trial is for children aged 8-18 with acute lymphoblastic leukemia (ALL) who are in the maintenance phase of chemotherapy, can speak and read English, have no exercise contraindications as per their oncologist, live with parents/guardians who consent to participation, and don't have psychiatric or neurological disorders affecting study involvement.Check my eligibility

What is being tested?

The study aims to assess how moderate physical activity affects the quality of life and activity levels in pediatric patients undergoing maintenance chemotherapy for ALL. It will measure changes due to exercise during this treatment phase.See study design

What are the potential side effects?

Since the intervention involves physical activity rather than medication, side effects may include typical exercise-related responses such as muscle soreness or fatigue but should be minimal under medical supervision.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I do not have any mental or neurological conditions that would prevent me from participating.

Select...

I am a child with ALL and currently in the maintenance phase of my treatment.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Quality of Life Outcomes

Secondary outcome measures

Fatigue

Physical Activity

Sleep

Trial Design

1Treatment groups

Experimental Treatment

Group I: Physical ActivityExperimental Treatment1 Intervention

Single arm study where patients choose from physical activities after baseline assessment by PT. Activities include the following: Nintendo WII fit console, Xbox Kinect fit console and other sport activities.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Physical Activity

2019

Completed Phase 3

~4710

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Connecticut Children's Medical CenterLead Sponsor

71 Previous Clinical Trials

31,489 Total Patients Enrolled

Andrea Orsey, MDPrincipal Investigator - Connecticut Children's Medical Center

Connecticut Children's Medical Center

University Of Connecticut School Of Medicine (Medical School)

Children'S Hosp-Philadelphia (Residency)

1 Previous Clinical Trials

23 Total Patients Enrolled

Media Library

Physical Activity Clinical Trial Eligibility Overview. Trial Name: NCT03132948 — N/A

Quality of Life Research Study Groups: Physical Activity

Quality of Life Clinical Trial 2023: Physical Activity Highlights & Side Effects. Trial Name: NCT03132948 — N/A

Physical Activity 2023 Treatment Timeline for Medical Study. Trial Name: NCT03132948 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this clinical experiment encompass those over the age of 55?

"This study requires prospective participants to be aged 8-18 years. According to the criteria, there are 333 clinical trials that accept minors and 735 studies welcoming senior adults."

Answered by AI

Do I meet the requirements to participate in this trial?

"This experimental trial is taking 25 minors, aged between 8 and 18, suffering from acute lymphocytic leukemia (L1). Other prerequisites include no psychiatric or neurological issues that would hinder the study, parental/guardian permission as well as patient assent to partake in the research project, being able to endure moderate physical activity without any contraindications determined by oncologists and pediatricians."

Answered by AI

What is the upper limit of participants involved in this investigation?

"Affirmative. Per the data provided on clinicaltrials.gov, this investigation is actively recruiting participants as of today's date. This trial was initiated October 1st 2010 and remains open for enrollment with a current requirement of 25 patients at one site."

Answered by AI

Are new participants being recruited for this research project?

"The clinical trial is still open for enrolment according to the information hosted on clinicaltrials.gov, which was last updated September 19th 2022. This medical study has been recruiting patients since October 1st 2010."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy

Andrea Orsey 2010. "Quality of Life in Pediatric Patients With Acute Lymphoblastic Leukemia Receiving Maintenance Chemotherapy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03132948.

All > All